2021
DOI: 10.1515/revneuro-2020-0128
|View full text |Cite
|
Sign up to set email alerts
|

The association of oxytocin with major depressive disorder: role of confounding effects of antidepressants

Abstract: Major depressive disorder is a genetic susceptible disease, and a psychiatric syndrome with a high rate of incidence and recurrence. Because of its complexity concerning etiology and pathogenesis, the cure rate of first-line antidepressants is low. In recent years, accumulative evidences revealed that oxytocin act as a physiological or pathological participant in a variety of complex neuropsychological activities, including major depressive disorder. Six electronic databases (Web of Science, PubMed, Scopus, Go… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 224 publications
0
8
0
Order By: Relevance
“…In general, the anti-depressive effect of OT is believed due to its regulating neuronal activity, influencing neuroplasticity and regeneration, altering neurotransmitter release, down-regulating hypothalamic-pituitary-adrenal (HPA) axis, anti-inflammation, antioxidation, and genetic effects ( Xie et al, 2022 ). As shown in studies on rats, excessive increase in glucocorticoids in chronic stress causes atrophy of the hippocampus ( Warfvinge et al, 2020 ), while central OT can activate GABA A -receptors in the PVN and thus inhibit acute restraint stress-induced corticotrophin-releasing hormone mRNA expression ( Bulbul et al, 2011 ) and the toxic effects of glucocorticoids ( Matsushita et al, 2019 ).…”
Section: Higher Brain Functionsmentioning
confidence: 99%
See 1 more Smart Citation
“…In general, the anti-depressive effect of OT is believed due to its regulating neuronal activity, influencing neuroplasticity and regeneration, altering neurotransmitter release, down-regulating hypothalamic-pituitary-adrenal (HPA) axis, anti-inflammation, antioxidation, and genetic effects ( Xie et al, 2022 ). As shown in studies on rats, excessive increase in glucocorticoids in chronic stress causes atrophy of the hippocampus ( Warfvinge et al, 2020 ), while central OT can activate GABA A -receptors in the PVN and thus inhibit acute restraint stress-induced corticotrophin-releasing hormone mRNA expression ( Bulbul et al, 2011 ) and the toxic effects of glucocorticoids ( Matsushita et al, 2019 ).…”
Section: Higher Brain Functionsmentioning
confidence: 99%
“…(1) (Cuneo et al, 2021;Jahangard et al, 2020;Meixner et al, 2019); (2) (Jung et al, 2021;Liu et al, 2021a;Maier et al, 2019;Wang et al, 2021b); (3) (Runyan et al, 2021;Sabe et al, 2021; (4) (John & Jaeggi, 2021;Shishido et al, 2021;Yoshihara et al, 2018;Yuan et al, 2019); (5) (Reichova et al, 2021;Tyzio et al, 2014); (6) (Francesconi et al, 2021;Huang et al, 2021;Jimenez et al, 2015;Li et al, 2020; (7) (Feifel et al, 2012;Guastella et al, 2008;Latt et al, 2018;Plasencia et al, 2019;Tse et al, 2018); (8) (Bertoni et al, 2021;Hu et al, 2015;Larrazolo-Lopez et al, 2008); (9) (Kreutzmann & Fendt, 2021;Takahashi et al, 2020 (10) (Fisher et al, 2021;La Fratta et al, 2021;Torres et al, 2022;Warrener et al, 2021); (11) (Borroto-Escuela et al, 2021;Matsushita et al, 2019;Xie et al, 2022;Yoshida et al, 2009); (12) …”
Section: Pro-social Behaviormentioning
confidence: 99%
“…Numerous animal and human research have implicated OT secretion problems in multiple mental illnesses, including depression, anxiety, schizophrenia, and autism spectrum disorders [36]. The antidepressant effects of OT are thought to be due to its modulation of neuronal activity, in uence on neuroplasticity and regeneration, alteration of neurotransmitter release, and downregulation of hypothalamic-pituitary-adrenal (HPA) axis, antiin ammatory, antioxidant and genetic effects [37].…”
Section: Discussionmentioning
confidence: 99%
“…One such biological factor is the peptide hormone, oxytocin. Oxytocin is thought to affect and be affected by depressive symptoms through various mechanisms including attenuation of cortisol release in response to stress, attenuation of proinflammatory cytokines, and modulation of brain regions involved in depression (24)(25)(26)(27)(28). Previous research has yielded variable results regarding the directionality of the relationship between oxytocin levels and depression.…”
Section: Introductionmentioning
confidence: 99%
“…This ambiguity has been captured in a recent qualitative review ( 28 ) and a meta-analysis comparing basal endogenous oxytocin concentrations in patients with depression versus healthy controls ( 36 ). Possible reasons for equivocal findings include sample differences in age, sex ( 27 , 37 ), and the clinical severity of depressive symptoms. In addition, heterogenous findings may be the result of sampling only one or a few time points, which provides only a brief snapshot of the dynamic oxytocin system.…”
Section: Introductionmentioning
confidence: 99%